Harmful body care products - An insight into a possible detoxification pathway in humans by AKR1B1 and AKR1B10

被引：0
|
作者：
Appel, D. [1 ]
Hintzpeter, J. [1 ]
Martin, H. J. [1 ]
Maser, E. [1 ]
机构：
[1] Univ Med Sch Schleswig Holstein Campus Kiel, Inst Toxicol & Pharmacol Nat Scientists, Kiel, Germany
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2018年 / 391卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P90
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [21] A comprehensive computational approach for the identification of structure-based potential pharmacological candidates as selective AKR1B1 and AKR1B10 inhibitors: repurposing of purine alkaloids for the treatment of cancer
    Aziz, Mubashir
    Ejaz, Syeda Abida
    Tamam, Nissren
    Siddique, Farhan
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (16): : 7892 - 7912
  • [22] Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse
    Rajak, Sangam
    Gupta, Pratima
    Anjum, Baby
    Raza, Sana
    Tewari, Archana
    Ghosh, Sujoy
    Tripathi, Madhulika
    Singh, Brijesh K.
    Sinha, Rohit A.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2022, 1868 (04):
  • [23] AKR1B10, a good prognostic indicator in gastric cancer
    Yao, H. -B.
    Xu, Y.
    Chen, L. -G.
    Guan, T. -P
    Ma, Y-Y
    He, X. -J.
    Xia, Y. -J.
    Tao, H. -Q.
    Shao, Q. -S.
    EJSO, 2014, 40 (03): : 318 - 324
  • [24] Overexpression of AKR1B10 in nasopharyngeal carcinoma as a potential biomarker
    He, Ying-Chun
    Shen, Yi
    Cao, Yu
    Tang, Fang-Qing
    Tian, Dao-Fa
    Huang, Chen-Fei
    Tao, Huai
    Zhou, Fang-Liang
    Zhang, Bo
    Song, Lan
    He, Lan
    Lin, Li-Mei
    Lu, Fang-Guo
    Liao, Duan-Fang
    Cao, Deliang
    CANCER BIOMARKERS, 2016, 16 (01) : 127 - 135
  • [25] EXPLORING THE ROLE OF AKR1B10 UPREGULATION IN HUMAN NASH
    Rady, Brian
    HEPATOLOGY, 2020, 72 : 326A - 327A
  • [26] AKR1B10, a new prognostic indicator in nasopharyngeal carcinoma
    Luo, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S166 - S166
  • [27] Murine aldo-keto reductase family 1 subfamily B: identification of AKR1B8 as an ortholog of human AKR1B10
    Joshi, Amit
    Rajput, Sandeep
    Wang, Chun
    Ma, Jun
    Cao, Deliang
    BIOLOGICAL CHEMISTRY, 2010, 391 (12) : 1371 - 1378
  • [28] Regulation of AKR1B1 by thyroid hormone and its receptors
    Liao, Chen-Shin
    Tai, Pei-Ju
    Huang, Ya-Hui
    Chen, Ruey-Nan
    Wu, Sheng-Ming
    Kuo, Lu-Wei
    Yeh, Chau-Ting
    Tsai, Ming-Ming
    Chen, Wei-Jan
    Lin, Kwang-Huei
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 307 (1-2) : 109 - 117
  • [29] AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy
    Shaw, Nicholas
    Yang, Bingmei
    Millward, Ann
    Demaine, Andrew
    Hodgkinson, Andrea
    CELL STRESS & CHAPERONES, 2014, 19 (02): : 281 - 287
  • [30] Structural analysis of sulindac as an inhibitor of aldose reductase and AKR1B10
    Cousido-Siah, Alexandra
    Ruiz, Francesc X.
    Crespo, Isidro
    Porte, Sergio
    Mitschler, Andre
    Pares, Xavier
    Podjarny, Alberto
    Farres, Jaume
    CHEMICO-BIOLOGICAL INTERACTIONS, 2015, 234 : 290 - 296
12345